OLD: Cafepharma Detail Piece Daily Pharma Headlines Archive for March, 2016

IMPORTANT: On Sunday, April 22, we send out an email with some important changes to our newsletter service. Please make sure you read this email, or the details on our our newsletter page, as our newsletter service changes will be taking effect on Monday, May 7, 2018.  On that date, your current newsletter subscription will end if you have not subscribed under our new plan. 

Click a link below to view the mailing archive as if it had been sent to you. 2016-03-31 12:15 Buying These 2 Drug Developers Would Make a Lot of Sense for Johnson &amp; Johnson and more... 2016-03-31 00:15 Medivation working with JPMorgan on takeover approaches -sources and more... 2016-03-30 12:15 How Did Martin Shkreli Ever Become A Pharmaceutical CEO? and more... 2016-03-30 00:15 8 Major Biopharma Events Coming Later in 2016 and in 2017 and more... 2016-03-29 12:15 Shire prevails in Lialda patent case against Allergan and more... 2016-03-29 00:15 Valeant CEO Pearson Subpoenaed to Testify at Senate Hearing and more... 2016-03-28 12:15 Sprout investors reportedly allege Valeant overpriced Addyi and more... 2016-03-27 00:15 Patent Payoff? Merck's and Ionis Pharmaceuticals' Take Could Be Tiny and more... 2016-03-25 12:15 Gilead to Pay Merck $200 Million in Damages Over Hepatitis C Drug Patents and more... 2016-03-25 00:15 GSK chief Witty may be leaving, but he hopes his strategy sticks around and more... 2016-03-24 12:15 Roche CEO Schwan beats Novartis chief with $12.3M in 2015 pay, but U.S. companies shell out more and more... 2016-03-24 00:15 http://cnb.cx/1pJ9n8E and more... 2016-03-23 12:15 Bill Ackman’s plan to fix Valeant is doomed and more... 2016-03-23 00:15 Amgen's PCSK9 patent win 'reasonably likely' to push Sanofi's Praluent off the market: Analyst and more... 2016-03-22 12:15 J&amp;J, BMS are delivering solid sales from new meds. The rest of Big Pharma, not so much: Forbes and more... 2016-03-22 00:15 GlaxoSmithKline's Search for a New CEO May Revive Underlying Uncertainties and more... 2016-03-21 12:15 Valeant's Pearson will step down as CEO; Ackman joins Board and more... 2016-03-21 00:15 4 Key Biopharma Movers of the Past Week and more... 2016-03-20 00:15 You'll Never Guess Which Pharma Likely Owns 40% of 2016's New Blockbusters and more... 2016-03-18 12:15 Gilead And The $3 Billion Merck Issue and more... 2016-03-18 00:15 Cholesterol pill boosts cancer immunotherapy, at least in mice and more... 2016-03-17 12:15 Germany's Bayer wins U.S. FDA approval for hemophilia A therapy and more... 2016-03-17 00:15 4 More Key FDA Decisions in March and more... 2016-03-16 12:15 Takeda and Frazier back a $41M round for a new urology biotech and more... 2016-03-16 00:15 Spectrum's once-rejected cancer drug wins FDA approval and more... 2016-03-15 12:15 Orexigen buys U.S. obesity pill rights from Takeda, partners Valeant and more... 2016-03-15 00:15 Merck's Keytruda held back by docs who don't want to wait for diagnostics and more... 2016-03-14 12:15 Pfizer stops selling popular Corex cough syrup in India after ban and more... 2016-03-14 00:15 [video]3 Big Risks Biotech Stocks Face and more... 2016-03-12 12:15 GlaxoSmithKline dumps Five Prime's cancer drug in the midst of Phase I and more... 2016-03-11 12:15 Sanofi Drug Beats AbbVie's Blockbuster Humira in Human Trial and more... 2016-03-11 00:15 MannKind (MNKD) Stock Spiked Ahead of Q4 Earnings and more... 2016-03-10 12:15 Here's How Ziopharm Oncology Hopes to Win the CAR-T Race and more... 2016-03-10 00:15 Orexigen takes another body blow from ill-fated Contrave trial and more... 2016-03-09 12:15 What’s in a biotech name? How drug startups choose their brand and more... 2016-03-09 00:15 What Ted Cruz Gets Wrong About The FDA: Tough Regulation Can Spark Innovation and more... 2016-03-08 12:15 Amgen Is Open to Bigger Deals While Staying Disciplined and more... 2016-03-08 00:15 Who Is Gilead Going To Buy? and more... 2016-03-07 12:15 Blind Pfizer sales rep battles for a car and driver to visit doctors and more... 2016-03-07 00:15 Senators propose an end to pharma ad tax deduction and more... 2016-03-06 12:15 Keytruda: Merck’s New Blockbuster for Its Immuno-Oncology Franchise and more... 2016-03-05 12:15 Kite, Juno ramping up commercial manufacturing capacity for CAR-T and more... 2016-03-05 00:15 Gilead: Hep C Prescriptions Hold at 94% Among New Patients and more... 2016-03-04 00:15 Head of Valeant's embattled dermatology unit exits in management shakeup and more... 2016-03-03 12:15 Are Drug Companies Reaping Extra Profits By Selling Oversized Doses Of Cancer Drugs? and more... 2016-03-02 12:15 Gilead Sciences, Inc Widens HIV Lead over GSK with Odefsey’s Approval and more... 2016-03-02 00:15 FDA and Product Jurisdiction: Time for Reforms and more... 2016-03-01 12:15 Pearson sweeps back into Valeant with a slate of fix-it promises and more... 2016-03-01 00:15 Arena Pharmaceuticals reports 4Q loss and more...   << Archive Index • Subscribe >>   Subscription preference center Archive Powered by FeedBlitz

Contact Us Past Issues Unsubscribe